they voted for emergency use authorization, then the cdc would take a look at this. the cdc had said that it was possible if everything went well to have shots in arms by president's day. earlier this week pfizer's ceo seemed confident that the fda would take a look at this and authorize this. as you mentioned just yesterday president biden told lester we were on the verge of this as well. so this is a significant change. so why, you know, what's the significance here in terms of why didn't they wait until submitting this emergency use authorization application when it had more complete data? you'll remember there was a lot of pressure to get this vaccine to the youngest children. in december late last year, pfizer said that two doses did not provide a significant enough immune response but it didn't have the data for the third dose. now these are smaller doses than